Cystic fibrosis in 2008;La mucoviscidose en 2008

Revue de Medecine Interne

Volumn 29, Issue 11, 2008, Pages 901-907

  Durieu, I ^a   Nove Josserand, R ^a  

^a Groupement Hospitalier Sud   (France)

Author keywords

Chronic respiratory insufficiency; Cystic fibrosis; Late onset disease; Orphan disease; Reference centre

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

AGENESIS; BRONCHIECTASIS; BRONCHOPULMONARY ASPERGILLOMA; BRONCHUS DISEASE; CHOLANGITIS; CLINICAL FEATURE; CYSTIC FIBROSIS; DELAYED DIAGNOSIS; DIABETES MELLITUS; FRANCE; HEALTH CARE ORGANIZATION; HUMAN; LIFE EXPECTANCY; LIVER DISEASE; LUNG DISEASE; MORBIDITY; MORTALITY; NEWBORN SCREENING; OSTEOPOROSIS; PANCREAS INSUFFICIENCY; PANCREATITIS; PATHOPHYSIOLOGY; PHENOTYPE; RECURRENT DISEASE; RESPIRATORY FAILURE; RHINOSINUSITIS; SHORT SURVEY; VAS DEFERENS;

ADULT; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FRANCE; GENE THERAPY; HUMANS; LIFE EXPECTANCY; LUNG DISEASES; MUTATION; NUTRITIONAL STATUS; PHENOTYPE; REGISTRIES;

EID: 54049112289     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2007.12.020     Document Type: Short Survey

References (45)

1. Observatoire National de la mucoviscidose. Bilan des données 2004. Vaincre la mucoviscidose et INED. Paris 2006.
2. Cystic Fibrosis Foundation. Patient registry 2004 annual report. Bethesda, Maryland 2005.
3. Goss C.H., and Rosenfeld M. Update on cystic fibrosis epidemiology. Curr Opin Pulm Med 10 (2004) 510-514
4. Trulock E.P., Edwards L.B., Taylor D.O., Boucek M.M., Kech B.M., and Hertz M.I. Registry of the International Society fort heart and lung transplantation: twenty-third official adult lung and heartlung transplantation report - 2006. J Heart Lung Transplant 25 (2006) 880-892
5. Riordan J.R., Rommens J.M., Kerem B., Alon N., Rozmahel R., Grzelczak Z., et al. Identification of cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245 (1989) 1066-1073
6. Kerem B., Rommens J.M., Buchanan J.A., Markiewicz D., Cox T.K., Chakravarti A., et al. Identification of the cystic fibrosis gene: genetic analysis. Science 245 (1989) 1073-1080
7. Rommens J.M., Iannuzzi M.C., Kerem B., Drumm M.L., Melmer G., Dean M., et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245 (1989) 1059-1065
8. Conférence de consensus: prise en charge du patient atteint de mucoviscidose. Novembre 2002 HAS.
9. Zeitling P.L. Emerging drug treatments for cystic fibrosis. Expert Opin Emerg Drugs 12 (2007) 329-336
10. http://www.genet.sickkids.on.ca/cftr.
11. Mehta A. CFTR: More than just a chloride channel. Pediatr Pulmonol 39 (2005) 292-298
12. Zeitlin. Novel pharmacologic therapies for cystic fibrosis. J Clin Invest 103 (1999) 447-452
13. Rosenstein B.J., Cutting G.R., and Cystic Fibrosis Foundation Consensus Panel. The diagnosis of cystic fibrosis. J Pediatr 132 (1998) 589-595
14. WHO. Classification of cystic fibrosis and related disorders (2000), World Health Organization, Stockholm
15. Ratjen F., and Doring G. Cystic fibrosis. Lancet 361 (2003) 681-689
16. Judge E.P., Dodd J.D., Masterson J.B., and Gallagher C.G. Pulmonary abnormalities on high-resolution CT demonstrate more rapid decline than FEV1 in adults with cystic fibrosis. Chest 130 (2006) 1424-1432
17. Wilschanski M., and Durie P.R. Patterns of gastro-intestinal disease in adulthood associated with mutations in the CFTR gene. Gut 56 (2007) 1153-1163
18. Moran A., Hardin D., and Rodman D. Diagnosis screening and management of cystic fibrosis related Diabetes mellitus: a conference report. Diabetes Res Clin Pract 45 (1999) 61-73
19. Corey M., Mc Langhin F.J., Williams M., and Levison H. A comparison of survival, growth and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol 41 (1988) 583-591
20. Lai H.C., Corey M., Fitzsimmons S., Kosorok M.R., and Farrell P.M. Comparison of growth status of patients with cystic fibrosis between the United States and Canada. Am J Clin Nutr 69 (1999) 531-538
21. Colombo C. Liver disease in cystic fibrosis. Curr Opin Pulm Med 13 (2007) 529-536
22. Durieu I., Pellet O., Simonot L., Durupt S., Bellon G., and Vital Durand D. Sclerosing cholangitic cystis fibrosis: a magnetic resonance cholangiographic study. J Hepatol 30 (1999) 1052-1056
23. Conway S.P., Morton A., Oldroyd B., Truscott J.G., White H., Smith A.H., et al. Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors. Thorax 55 (2000) 798-804
24. Aris RM. Pathogenesis of CF bone disease. Pediatric Pulmonology 2002;S24:177
25. Aris R.M., Merkel P.A., Bachrach L.K., Borowitz D.S., Boyle M.P., Elkin S.L., et al. Consensus Conference Report: Guide to bone health and disease in cystic fibrosis. J Clin Endoc Metab 90 (2005) 1888-1896
26. Merkel P.A. Rheumatic disease and cystic fibrosis. Arthritis Rheum 42 (1999) 1563-1571
27. Doyen V., Fournier C., Bautin N., Cortet B., Flipo R.M., and Wallaert B. Rheumatoid arthritis and cystic fibrosis. Rev Mal Respir 22 (2005) 667-671
28. Nick J.A., and Rodman D.M. Manifestations of cystic fibrosis diagnosed in adulthood. Curr Opin Pulm Med 11 (2005) 513-518
29. Boyle M.P. Nonclassic cystic fibrosis and CFTR-related disease. Curr Opin Pulm Med 9 (2003) 498-503
30. Noone P.G., and Knowles M.R. CFTR-opathies: disesase phenotypes associated with cystic fibrosis transmembrane regulator gene mutations. Respir Res 2 (2001) 328-332
31. Southern K.W. Cystic fibrosis and formes frustres of CFTR related disease. Respiration 74 (2007) 241-251
32. Chillon M., Casals T., Mercier B., Bassas L., Lissens W., Silber S., et al. Mutations in the cystis fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med 332 (1995) 1475-1480
33. Durieu I., Bey-Omar F., Rollet J., Calemard L., Boggio D., Lejeune H., et al. Diagnostic criteria for cystic fibrosis in men with congenital absence of the vas deferens. Medicine 74 (1995) 42-47
34. Nove-josserand R., Bey-Omar F., Rollet J., Lejeune H., Boggio D., Vital Durand D., et al. Cystic fibrosis phenotype evaluation and paternity outcome in 50 males with congenital bilateral absence of vas deferens. Hum Reprod 16 (2001) 2093-2097
35. Gibson R.L., Burns J.L., and Ramsey B.W. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 168 (2003) 918-951
36. Witt H., Apte M.V., Keim V., and Wilson J.S. Chronic pancreatitis: challenge and advances in pathogenesis genetics, diagnostics, and therapy. Gastroenterology 132 (2007) 1557-1573
37. Yankaskas J.R., Marshall B.C., Sufian B., Simon R.H., and Rodman D. Cystic fibrosis adult care. Chest 125 (2004) 1s-39s
38. Accurso F.J. Update in cystic fibrosis 2006. Am J Respir Crit Care Med 175 (2007) 754-757
39. Mac Ardle J.R., and Talwalker J.S. Macrolides in cystic fibrosis. Clin Chest Med 28 (2007) 347-360
40. Elkins M.R., Robinson M., Rose B.R., Harbour C., Moriarty C.P., Marks G.B., et al. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med 354 (2006) 229-240
41. Prescott W.A., and Johnson C.E. Antiinflammatory therapies for cystic fibrosis: past, present, and future. Pharmacotherapy 25 (2005) 555-573
42. Ratjen F. New pulmonary therapies for cystic fibrosis. Curr Opin Pulm Med 13 (2007) 541-546
43. Balfour-Lynn I. Anti Inflammatory approaches to cystic fibrosis airways diseases. Curr Opin Pulm Med 13 (2007) 522-528
44. Alton E. Progress and Prospects: Gene therapy clinical trials. Gene Ther 14 (2007) 1439-1447
45. Norez C., Noel S., Wilke M., Bijvelds M., Jorna J., Melin P., et al. Rescue of functional DelF508-CFTR channels in cystic fibrosis epithelial cells by the alpha-glucosidase inhibitor miglustat. FEBS Lett 580 (2006) 2081-2086